BioCentury
ARTICLE | Company News

Bradbury to become Amylin CEO

June 7, 2006 11:28 PM UTC

AMLN promoted Daniel Bradbury to president while remaining COO. He replaces CEO Ginger Graham as president and will assume the CEO post within a year. The endocrine and cardiovascular company also app...